[1]张开均 李谧.肺动脉分支狭窄支架治疗研究进展[J].心血管病学进展,2022,(11):988.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.006]
　ZHANG Kaijun,LI Mi.Stenting for Pulmonary Branch Stenosis[J].Advances in Cardiovascular Diseases,2022,(11):988.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.006]
点击复制

肺动脉分支狭窄支架治疗研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年11期
页码:
988
栏目:
综述
出版日期:
2022-11-25

文章信息/Info

Title:
Stenting for Pulmonary Branch Stenosis
作者:
张开均 李谧
(重庆医科大学附属儿童医院心血管内科 国家儿童健康与疾病临床医学研究中心 儿童发育疾病研究教育部重点实验室 儿科学重庆市重点实验室,重庆400014)
Author(s):
ZHANG Kaijun;  LI Mi
(Department of Cardiology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014,China )
关键词:
肺动脉分支狭窄; 肺动脉支架; 肺动脉支架植入术
Keywords:
Pulmonary branch stenosis;  Pulmonary artery stent;  Pulmonary artery stent implantation
DOI:
10.16806/j.cnki.issn.1004-3934.2022.11.006
摘要:
肺动脉分支狭窄是常见的儿童血管畸形之一。未经治疗的肺动脉分支狭窄会导致狭窄远端的肺血管床发育不良以及未发生狭窄的对侧肺血管持续性高肺动脉压力，进而导致右心衰竭甚至危及生命。内科介入治疗是外科治疗的替代治疗，在复杂先天性心脏病外科术后等特殊人群甚至是首选治疗方式。随着材料学的进步，肺动脉支架蓬勃发展、前景广阔，广泛应用于肺动脉分支狭窄的介入治疗。为了帮助临床医师了解肺动脉支架的相关研究进展，现概述不同类型支架在肺动脉分支狭窄中的应用。
Abstract:
Pulmonary branch stenosis(PBS) is one of the most common vascular malformations in children. Untreated PBS can result in a hypoplastic pulmonary vascular bed distal to the stenosis and persistent high pulmonary artery pressure in the contralateral pulmonary vessels without stenosis, leading to right heart failure or even life-threatening conditions. Intervention therapy is an alternative to surgery and is even the preferred treatment in special populations such as children after undergoing complex congenital heart disease surgery. With the progress of material science, pulmonary artery stents have been widely used in interventional therapy of PBS. To help clinicians better keep pace with the related research advances, an overview of the different types of stents used in PBS is presented.

参考文献/References:

[1] Feltes TF,Bacha E,Beekman RH 3rd ,et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease:a scientific statement from the American Heart Association[J]. Circulation,2011,123(22):2607-2652.

[2] Kumar N,Hussain N,Kumar J,et al. Evaluating the impact of pulmonary artery obstruction after lung transplant surgery:a systematic review and meta-analysis[J]. Transplantation,2021,105(4):711-722.

[3] Martin E,Mainwaring RD,Collins RT 2nd,et al. Surgical repair of peripheral pulmonary artery stenosis in patients without Williams or Alagille syndromes[J]. Semin Thorac Cardiovasc Surg,2020,32(4):973-979.

[4] Hiremath G,Qureshi AM,Prieto LR,et al. Balloon angioplasty and stenting for unilateral branch pulmonary artery stenosis improve exertional performance[J]. JACC Cardiovasc Interv,2019,12(3):289-297.

[5] Nielsen EA,Hjortdal VE. Surgically treated pulmonary stenosis:over 50 years of follow-up[J]. Cardiol Young,2016,26(5):860-866.

[6] Bush DM,Hoffman TM,del Rosario J,et al. Frequency of restenosis after balloon pulmonary arterioplasty and its causes[J]. Am J Cardiol,2000,86(11):1205-1209.

[7] O’Laughlin MP,Perry SB,Lock JE,et al. Use of endovascular stents in congenital heart disease[J]. Circulation,1991,83(6):1923-1939.

[8] Vida VL,Rito ML,Zucchetta F,et al. Pulmonary artery branch stenosis in patients with congenital heart disease[J]. J Card Surg,2013,28(4):439-445.

[9] Peters B,Ewert P,Berger F. The role of stents in the treatment of congenital heart disease:current status and future perspectives[J]. Ann Pediatr Cardiol,2009,2(1):3-23.

[10] Zampi JD,Loccoh E,Armstrong AK,et al. Twenty years of experience with intraoperative pulmonary artery stenting[J]. Catheter Cardiovasc Interv,2017,90(3):398-406.

[11] Ooi YK,Kim SIH,Gillespie SE,et al. Premounted stents for branch pulmonary artery stenosis in children:a short term solution[J]. Catheter Cardiovasc Interv,2018,92(7):1315-1322.

[12] Noonan P,Kudumula V,Anderson B,et al. Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome[J]. Catheter Cardiovasc Interv,2016,88(2):225-232.

[13] Zou H,Li SQ. Percutaneous pulmonary artery biodegradable stent:a new armament to fight pulmonary artery stenosis?[J]. Chin Med J(Engl),2020,133(19):2389-2391.

[14] 王婧婷,茆致康,丁文虹,等. 儿童肺动脉分支狭窄的治疗现状[J]. 心肺血管病杂志,2019,38(9):1000-1003.

[15] Patel ND,Kenny D,Gonzalez I,et al. Single-center outcome analysis comparing reintervention rates of surgical arterioplasty with stenting for branch pulmonary artery stenosis in a pediatric population[J]. Pediatr Cardiol,2014,35(3):419-422.

[16] Duke C,Rosenthal E,Qureshi SA. The efficacy and safety of stent redilatation in congenital heart disease[J]. Heart,2003,89(8):905-912.

[17] Schneider MB,Zartner P,Duveneck K,et al. Various reasons for repeat dilatation of stented pulmonary arteries in paediatric patients[J]. Heart,2002,88(5):505-509.

[18] Fischman DL,Leon MB,Baim DS,et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease.Stent Restenosis Study Investigators[J]. N Engl J Med,1994,331(8):496-501.

[19] Schatz RA,Baim DS,Leon M,et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study[J]. Circulation,1991,83(1):148-161.

[20] Laham RJ,Carrozza JP,Berger C,et al. Long-term(4- to 6-year) outcome of Palmaz-Schatz stenting:paucity of late clinical stent-related problems[J]. J Am Coll Cardiol,1996,28(4):820-826.

[21] Ma I,El Arid JM,Neville P,et al. Long-term evolution of stents implanted in branch pulmonary arteries[J]. Arch Cardiovasc Dis,2021,114(1):33-40.

[22] Holzer RJ,Gauvreau K,McEnaney K,et al. Long-term outcomes of the coarctation of the aorta stent trials[J]. Circ Cardiovasc Interv,2021,14(6):e10308.

[23] Agnoletti G,Marini D,Ou P,et al. Cheatham platinum(CP) and Palmaz stents for cardiac and vascular lesions treatment in patients with congenital heart disease[J]. EuroIntervention,2009,4(5):620-625.

[24] Zhao W,Li F,Zhou AQ,et al. Cheatham-Platinum stent implantation for pulmonary artery stenosis in children and adolescents:immediate and mid-term outcome[J]. World J Pediatr,2010,6(4):337-341.

[25] 郭颖,余志庆,刘廷亮,等. 血管内支架在儿童肺动脉分支狭窄中的应用[J]. 中华儿科杂志,2014,52(5):358-361.

[26] 刘廷亮,郭颖,高伟,等. 应用新型Pul-Stent支架治疗外科术后肺动脉分支狭窄的初步临床研究[J]. 中华儿科杂志,2015,53(3):208-213.

[27] 石诗,金梅,丁文虹,等. 肺动脉支架治疗儿童肺动脉分支狭窄近中期右心功能随访研究[J]. 心肺血管病杂志,2017,36(8):674-677.

[28] 万俊义,张戈军,潘湘斌,等. 应用新型Pul-Stent支架治疗肺动脉分支狭窄的临床研究[J]. 中国循环杂志,2019,34(9):904-908.

[29] McMahon CJ,El-Said HG,Grifka RG,et al. Redilation of endovascular stents in congenital heart disease:factors implicated in the development of restenosis and neointimal proliferation[J]. J Am Coll Cardiol,2001,38(2):521-526.

[30] Zartner P,Buettner M,Singer H,et al. First biodegradable metal stent in a child with congenital heart disease:evaluation of macro and histopathology[J]. Catheter Cardiovasc Interv,2007,69(3):443-446.

[31] Cassese S,Byrne RA,Ndrepepa G,et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents:a meta-analysis of randomised controlled trials[J]. Lancet,2016,387(10018):537-544.

[32] Serruys PW,Katagiri Y,Sotomi Y,et al. Arterial remodeling after bioresorbable scaffolds and metallic stents[J]. J Am Coll Cardiol,2017,70(1):60-74.

[33] 孙春平,张智伟,谢育梅,等. 经皮介入治疗儿童肺动脉分支狭窄疗效观察[J]. 临床儿科杂志,2020,38(7):497-500.

[34] 谢育梅,张智伟,李俊杰,等. 血管支架植入治疗复杂先心病外科术后分支肺动脉狭窄[C]. 第16届中国南方国际心血管病学术会议,2014:99-100.

[35] Bersin RM,Ansel G,Rizzo A,et al. Nine-month results of the REFORM study:a prospective,single-arm,multicenter clinical study of the safety and effectiveness of the Formula? balloon-expandable stent for treatment of renal artery stenosis[J]. Catheter Cardiovasc Interv,2013,82(2):266-273.

[36] Quandt D,Ramchandani B,Bhole V,et al. Initial experience with the cook formula balloon expandable stent in congenital heart disease[J]. Catheter Cardiovasc Interv,2015,85(2):259-266.

[37] Travelli FC,Sullivan PM,Takao C,et al. The Valeo stent:a pre-mounted, open-cell,large stent for use in small children with CHD[J]. Cardiol Young,2016,26(6):1187-1193.

[38] Ovaert C,Luciano D,Gaudart J,et al. The VALEO vascular stent for cardiovascular lesions in children[J]. EuroIntervention,2015,10(11):1326-1331.

[39] Kudumula V,Noonan P,Taliotis D,et al. Implantation and preliminary follow-up of the Bard Valeo stent in pulmonary artery stenosis[J]. Catheter Cardiovasc Interv,2014,84(2):197-203.

[40] Quandt D,Knirsch W,Michel-Behnke I,et al. First-in-man pulmonary artery stenting in children using the Bentley? BeGrow?stent system for newborns and infants[J]. Int J Cardiol,2019,276:107-109.

更新日期/Last Update: 2023-01-31